These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20147432)

  • 21. Pregabalin treatment of anxiety in patients with substance use disorders.
    Raza S; Siddiqui UA; Megna JL; Schwartz TL; Batki SL
    Ann Pharmacother; 2010 May; 44(5):937-8. PubMed ID: 20388860
    [No Abstract]   [Full Text] [Related]  

  • 22. A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD).
    Davidson JR; Zhang W; Connor KM; Ji J; Jobson K; Lecrubier Y; McFarlane AC; Newport DJ; Nutt DJ; Osser DN; Stein DJ; Stowe ZN; Tajima O; Versiani M
    J Psychopharmacol; 2010 Jan; 24(1):3-26. PubMed ID: 18832431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregabalin: a new anxiolytic.
    Lauria-Horner BA; Pohl RB
    Expert Opin Investig Drugs; 2003 Apr; 12(4):663-72. PubMed ID: 12665421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies.
    Stein DJ; Baldwin DS; Baldinetti F; Mandel F
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):422-30. PubMed ID: 18359203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [No evidence for tolerance in the treatment of anxiety with pregabalin (Lyrica)].
    Andersson M; Lindh J
    Lakartidningen; 2010 Apr 28-May 4; 107(17):1161. PubMed ID: 20518384
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of pregabalin on sleep in generalized anxiety disorder.
    Holsboer-Trachsler E; Prieto R
    Int J Neuropsychopharmacol; 2013 May; 16(4):925-36. PubMed ID: 23009881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregabalin: in the treatment of generalised anxiety disorder.
    Frampton JE; Foster RH
    CNS Drugs; 2006; 20(8):685-93; discussion 694-5. PubMed ID: 16863276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of pregabalin in generalised anxiety disorder: A critical review of the literature.
    Baldwin DS; den Boer JA; Lyndon G; Emir B; Schweizer E; Haswell H
    J Psychopharmacol; 2015 Oct; 29(10):1047-60. PubMed ID: 26259772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregabalin in the discontinuation of long-term benzodiazepines' use.
    Oulis P; Konstantakopoulos G; Kouzoupis AV; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kontoangelos KA; Papadimitriou GN
    Hum Psychopharmacol; 2008 Jun; 23(4):337-40. PubMed ID: 18348245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pregabalin--a neuromodulator for the treatment of neuropathic pain, generalized anxiety disorders and fibromyalgia syndrome].
    Nymdelger S; Nieber K
    Med Monatsschr Pharm; 2007 Nov; 30(11):396-400. PubMed ID: 18062330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute pregabalin reversal of citalopram-induced sexual dysfunction in generalized anxiety disorder.
    Oulis P; Kouzoupis AV; Koulouris G; Masdrakis VG; Kontoangelos K; Matsoukas T; Papadimitriou GN
    J Clin Psychopharmacol; 2008 Jun; 28(3):362-63. PubMed ID: 18480692
    [No Abstract]   [Full Text] [Related]  

  • 33. Does Pregabalin (Lyrica(®) ) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database.
    Bramness JG; Sandvik P; Engeland A; Skurtveit S
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):883-6. PubMed ID: 22545971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.
    Feltner DE; Crockatt JG; Dubovsky SJ; Cohn CK; Shrivastava RK; Targum SD; Liu-Dumaw M; Carter CM; Pande AC
    J Clin Psychopharmacol; 2003 Jun; 23(3):240-9. PubMed ID: 12826986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model.
    Nutt D; Mandel F; Baldinetti F
    J Psychopharmacol; 2009 Nov; 23(8):867-73. PubMed ID: 18635690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregabalin in acute treatment of anxious depression: a case series.
    Anderson C; George D; Quante A
    Psychiatry Res; 2014 Jan; 215(1):246-8. PubMed ID: 24611161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating anxiety without SSRIs.
    Zoberi K; Pollard CA
    J Fam Pract; 2010 Mar; 59(3):148-54. PubMed ID: 20230732
    [No Abstract]   [Full Text] [Related]  

  • 38. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Hadley SJ; Mandel FS; Schweizer E
    J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neurobiological approach to anxiety].
    Boyer P
    Arch Mal Coeur Vaiss; 1987 May; 80 Spec No():43-6. PubMed ID: 2889436
    [No Abstract]   [Full Text] [Related]  

  • 40. Statement of the AGNP in the Context of the Planned Formation of a Fixed Reference Price Group "GABA-Analogues", November 21, 2011.
    Steiger A;
    Pharmacopsychiatry; 2012 Mar; 45(2):II. PubMed ID: 22426825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.